Last updated on February 2018

Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use

Brief description of study

This study will evaluate the efficacy and safety of eluxadoline 100 milligrams (mg) twice a day (BID) versus placebo for the treatment of patients with Irritable Bowel Syndrome with Diarrhea (IBS-D) who report that the use of loperamide in the prior 12 months failed to provide control of their IBS-D symptoms.

Clinical Study Identifier: NCT02959983

Contact Investigators or Research Sites near you

Start Over

Clinical Trials Registry Team

IMA Medical Research, PC
Kew Gardens, NY United States
  Connect »

Clinical Trials Registry Team

Long Island Gastrointestinal Group LLP
Great Neck, NY United States
  Connect »

Clinical Trials Registry Team

Drug Trials Brooklyn
Brooklyn, NY United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.